EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human-derived fecal microbiota transplantation alleviates social deficits of the BTBR mouse model of autism through a potential mechanism involving vitamin B 6 metabolism

Lifeng Zheng iD, Yinming Jiao iD, Haolin Zhong iD, Yan Tan, Yiming Yin, Yanhong Liu, Ding Liu, Manli Wu, Guoyun Wang, Jinqun Huang, Ping Wang, Meirong Qin und 7 weitere

mSystems · 18.06.2024 · 9 (6)

DOI: 10.1128/msystems.00257-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, erschienen am 18.06.2024. Verfasst von Lifeng Zheng und 18 weiteren Autor:innen. Beteiligte Einrichtung: Brain Research Centre and Department of Neuroscience, Southern University of Science and Technology, Shenzhen, China. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Disease Models, Animal, Vitamin B 6. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Sanming Project of Medicine in Shenzhen Nanshan, Major Program of Shenzhen Nanshan, MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by social communication deficiencies and stereotypic behaviors influenced by hereditary and/or environmental risk factors. There are currently no approved medications for treating the core symptoms of ASD. Human fecal microbiota transplantation (FMT) has emerged as a potential intervention to improve autistic symptoms, but the underlying mechanisms are not fully understood. In this study, we evaluated the effects of human-derived FMT on behavioral and multi-omics profiles of the BTBR mice, an established model for ASD. FMT effectively alleviated the social deficits in the BTBR mice and normalized their distinct plasma metabolic profile, notably reducing the elevated long-chain acylcarnitines. Integrative analysis linked these phenotypic changes to specific Bacteroides species and vitamin B 6 metabolism. Indeed, vitamin B 6 supplementation improved the social behaviors in BTBR mice. Collectively, these findings shed new light on the interplay between FMT and vitamin B 6 metabolism and revealed a potential mechanism underlying the therapeutic role of FMT in ASD. IMPORTANCE Accumulating evidence supports the beneficial effects of human fecal microbiota transplantation (FMT) on symptoms associated with autism spectrum disorder (ASD). However, the precise mechanism by which FMT induces a shift in the microbiota and leads to symptom improvement remains incompletely understood. This study integrated data from colon-content metagenomics, colon-content metabolomics, and plasma metabolomics to investigate the effects of FMT treatment on the BTBR mouse model for ASD. The analysis linked the amelioration of social deficits following FMT treatment to the restoration of mitochondrial function and the modulation of vitamin B 6 metabolism. Bacterial species and compounds with beneficial roles in vitamin B 6 metabolism and mitochondrial function may further contribute to improving FMT products and designing novel therapies for ASD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationDisease Models, AnimalVitamin B 6AnimalsMiceHumansGastrointestinal MicrobiomeMaleSocial BehaviorAutism Spectrum DisorderAutistic Disorder

Stichwörter der Autor:innen

BTBRBacteroidesautism spectrum disorder (ASD)fatty acid metabolismfecal microbiota transplantation (FMT)pyridoxal 5′-phosphate (PLP)social deficitvitamin B6 metabolism

Substanzen

Vitamin B 6

Autor:innen und Institutionen

  • Brain Research Centre and Department of Neuroscience, Southern University of Science and Technology, Shenzhen, China.
  • Xbiome Co. Ltd., Shenzhen, China.
  • Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, China.
  • Shenzhen Institute for Drug Control, Shenzhen, China.
  • Microbiome Therapy Center, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
  • Shanghai Key Laboratory of Birth Defects, Division of Neonatology, Children's Hospital of Fudan University, National Center for Children's Health, Shanghai, China.

ORCID-Profile: Lifeng Zheng, Yinming Jiao, Haolin Zhong, Mingbang Wang, Yang Xiao, Han Hu, Sheng-Tao Hou, Ling Kui

Förderung

  • The Sanming Project of Medicine in Shenzhen Nanshan
  • Major Program of Shenzhen Nanshan
  • MOST | National Natural Science Foundation of China (NSFC)
  • the Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions
  • Shenzhen Medical Research Fund

Zitieren

APA

Zheng, L., Jiao, Y., Zhong, H., Tan, Y., Yin, Y., Liu, Y., Liu, D., Wu, M., Wang, G., Huang, J., Wang, P., Qin, M., Wang, M., Xiao, Y., Lv, T., Luo, Y., Hu, H., Hou, S. T., & Kui, L. (2024). Human-derived fecal microbiota transplantation alleviates social deficits of the BTBR mouse model of autism through a potential mechanism involving vitamin B 6 metabolism. mSystems, 9(6). https://doi.org/10.1128/msystems.00257-24

Vancouver

Zheng L, Jiao Y, Zhong H, Tan Y, Yin Y, Liu Y, et al. Human-derived fecal microbiota transplantation alleviates social deficits of the BTBR mouse model of autism through a potential mechanism involving vitamin B 6 metabolism. mSystems. 2024;9(6). doi:10.1128/msystems.00257-24

BibTeX
@article{Zheng2024,
  author = {Zheng, Lifeng and Jiao, Yinming and Zhong, Haolin and Tan, Yan and Yin, Yiming and Liu, Yanhong and Liu, Ding and Wu, Manli and Wang, Guoyun and Huang, Jinqun and Wang, Ping and Qin, Meirong and Wang, Mingbang and Xiao, Yang and Lv, Tiying and Luo, Yangzi and Hu, Han and Hou, Sheng-Tao and Kui, Ling},
  title = {Human-derived fecal microbiota transplantation alleviates social deficits of the BTBR mouse model of autism through a potential mechanism involving vitamin B 6 metabolism},
  journal = {mSystems},
  year = {2024},
  volume = {9},
  number = {6},
  doi = {10.1128/msystems.00257-24}
}
Kostenlos starten →